PET/CT与PET/MR在软组织肉瘤中的应用:更新
本文聚焦儿童软组织肉瘤,重点阐述横纹肌肉瘤及非横纹肌肉瘤软组织肉瘤的分期、危险度分层、影像推荐和判读,主要依据儿童肿瘤协作组试验,并补充国际软组织肉瘤数据库联盟和欧洲试验的相关结果与建议。
要点
- 横纹肌肉瘤家族占儿童癌症3%,是儿童最常见的软组织肉瘤。
- 儿童软组织肉瘤的分期、危险度分层和影像推荐主要依据儿童肿瘤协作组试验。
- 文章补充国际软组织肉瘤数据库联盟和欧洲试验在相关章节的互补指南。
核心结论
- 本文主要依据儿童肿瘤协作组试验,阐述儿童软组织肉瘤的分期、危险度分层、影像推荐和判读。
- 国际软组织肉瘤数据库联盟和欧洲试验在相关章节提供互补指南。
研究设计与样本
- 综述,聚焦儿童软组织肉瘤的PET/CT与PET/MR影像应用更新。
- 主要依据儿童肿瘤协作组临床试验,并补充国际软组织肉瘤数据库联盟和欧洲试验的结果与建议。
主要发现
- 软组织肉瘤占儿童癌症的6%-8%。
- 横纹肌肉瘤家族占儿童癌症的3%,为儿童最常见软组织肉瘤,属高级别肿瘤且转移倾向高。
- 非横纹肌肉瘤软组织肉瘤占儿童癌症的3%-4%,包括低级别和高级别肿瘤。
- 北美多数儿童软组织肉瘤患者在儿童肿瘤协作组临床试验中接受治疗。
关键数值与推荐
- 横纹肌肉瘤采用风险适应、多模式治疗,联合手术、放疗和多药细胞毒化疗。
- 多数非横纹肌肉瘤软组织肉瘤以手术为主要治疗,许多病例需联合放疗和化疗的多模式治疗。
临床怎么用
- 儿童软组织肉瘤的分期、危险度分层、影像推荐和判读可参照儿童肿瘤协作组试验。
- 相关章节可参考国际软组织肉瘤数据库联盟和欧洲试验提供的互补指南。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Soft tissue sarcomas account for 6%-8% of pediatric cancers. The rhabdomyosarcoma family is the most frequent soft tissue sarcoma in this age group accounting for 3% of pediatric cancers. Rhabdomyosarcomas are high-grade tumors with a high propensity to metastasize. The risk-adapted, multimodal therapeutic approach for rhabdomyosarcomas incorporates a combination of surgery, radiotherapy, and multi-agent cytotoxic chemotherapy. Soft tissue sarcomas other than rhabdomyosarcoma account for 3%-4% of pediatric cancers. The nonrhabdomyosarcoma soft tissue sarcomas include both low-grade and high-grade tumors. While surgery is the mainstay of therapy in most non-rhabdomyosarcoma soft tissue sarcomas, many cases require a multimodal therapeutic approach including radiotherapy and chemotherapy. In North America, most pediatric patients with soft tissue sarcomas are treated in Children's Oncology Group clinical trials. In this article, we will primarily focus on the staging, risk stratification, imaging recommendations, and interpretations in accordance with the Children's Oncology Group trials. We will review the results and recommendations of International Soft Tissue Sarcoma Database Consortium and European trials in relevant sections where they provide complementary guidelines.
引用
- Khalatbari H, Shulkin BL, Parisi MT, et al. PET/CT and PET/MR in Soft Tissue Sarcoma: An Update. Semin Nucl Med. 2024. PMID: 38423851. doi:10.1053/j.semnuclmed.2024.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。